120. 遺伝性ジストニア
[臨床試験数:25,薬物数:22(DrugBank:4),標的遺伝子数:2,標的パスウェイ数:2

Searched query = "Hereditary dystonia", "DYT1 dystonia", "DYT2 dystonia", "DYT3 dystonia", "X-linked dystonia-parkinsonism", "Lubag", "DYT4 dystonia", "DYT5 dystonia", ... show all
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04182763
(ClinicalTrials.gov)
December 4, 201924/11/2019CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)A Phase 2 Study of a Vitamin Metabolite for PKANPantothenate Kinase-Associated NeurodegenerationOther: CoA-Z;Other: PlaceboOregon Health and Science UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);Washington State University;Oregon State University;Spoonbill FoundationRecruiting3 Months89 YearsAll51Phase 2United States